References

1. Phoenix C, Drexler E. Safe exponential manufacturing. Nanotechnology 2004;15:869-872.

2. Giles J. Nanotech takes small step towards burying 'grey goo'. Nature 2004;429:591-591.

3. Helm B. The worries over nano no-nos. Business Week Online, February 23, 2005.

4. Royal Society/Royal Academy of Engineering. Nanotechnologies: Opportunities and Uncertainties, 2004. http://www.nanotec.org.uk/finalReport.htm

5. President's Council of Advisors on Science and Technology. The National Nanotechnology Initiative at Five Years, Washington, DC, 2005. http://www.ostp.gov/pcast/ PCASTreportFINAL.pdf

6. Weiss R. Nanotech's frightening unknowns: It's like something from science fiction, yet it's being applied now—before Its effects Are properly understood. Most admit it's unstoppable, but will it prove benign or deadly? Washington Post, May 29, 2004.

7. Ross R. Big questions about tiny particles. Toronto Star, October 11, 2004.

8. Davidson K. The promise and perils of the nanotech revolution; possibilities range from disaster to advances in medicine, space. San Francisco Chronicle July 26, 2004.

9. Oberdorster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H. Principles for characterizing the potential human health effects from exposure to nanomaterials: Elements of a screening strategy, Particle Fiber Toxicol 2005;2:8.

10. Donaldson K, Stone V, Tran CL, Kreyling W, Borm PJ. Nanotoxicology Occup Environ Med 2004;61:727-728.

11. Hood E. Nanotechnology: Looking as we leap. Environ Health Perspect 2004;112: A740-A749.

12. Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Persp 2005;113:823-839.

13. Maynard A, Kuempel E. Airborne nanostructured particles and occupational health. JNanoparticle Res 2005;7:587.

14. Hoet PH, Bruske-Hohlfeld I, Salata OV. Nanoparticles—Known and unknown health risks. J Nanobiotechnol 2004;2:12.

15. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science 2006;311:622-627.

16. Thomas K, Sayre P. Research strategies for safety evaluation of nanomaterials, part I: Evaluating the human health implications of exposure to nanoscale materials. Toxicol Sci 2005;87:316-321.

17. Holsapple MP, Farland WH, Landry TD, Monteiro-Riviere NA, Carter JM, Walker NJ, Thomas KV. Research strategies for safety evaluation of nanomaterials, Part II: Toxicolog-ical and safety evaluation of nanomaterials, current challenges and data needs. Toxicol Sci 2005;88:12-17.

18. Tsuji JS, Maynard AD, Howard PC, James JT, Lam C-w, Warheit DB, Santamaria AB. Research strategies for safety evaluation of nanomaterials, Part IV: Risk assessment of nanoparticles. Toxicol Sci 2006;89:42-50.

19. Kagan VE, Tyurina YY, Tyurin VA, Konduru NV, Potapovich AI, Osipov AN, Kisin ER, Schwegler-Berry D, Mercer R, Castranova V, Shvedova AA. Direct and indirect effects of single walled carbon nanotubes on raw 264.7 macrophages: Role of iron. Toxicol Lett 2006;165:88-100.

20. Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, Li JJ, Sundaresan G, Wu AM, Gambhir SS, Weiss S. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005;307:538-544.

21. Allen TM, Cullis PR. Drug delivery systems: Entering the mainstream. Science 2004;303:1818-1822.

22. Koch AM, Reynolds F, Merkle HP, Weissleder R, Josephson L. Transport of surface-modified nanoparticles through cell monolayers. ChemBioChem 2005;6:337-345.

23. Win KY, Feng SS. Effects of Particle Size and Surface Coating on Cellular Uptake of Polymeric Nanoparticles for Oral Delivery of Anticancer Drugs. Biomaterials 2005;26:2713-2722.

24. Limbach LK, Li Y, Grass RN, Brunner TJ, Hintermann MA, Muller M, Gunther D, Stark WJ. Oxide nanoparticle uptake in human lung fibroblasts: Effects of particle size, agglomeration, and diffusion at low concentrations. Environ Sci Technol 2005;39:9370-9376.

25. Li N, Sioutas C, Cho A, Schmitz D, Misra C, Sempf J, Wang M, Oberley T, Froines J, Nel A. Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ Health Perspect 2003;111:455-460.

26. Fernandez-Urrusuno R, Fattal E, Feger J, Couvreur P, Therond P. Evaluation of hepatic antioxidant systems after intravenous administration of polymeric nanoparticles. Biomaterials 1997;18:511-517.

27. Zhang Q, Kusaka Y, Sato K, Nakakuki K, Kohyama N, Donaldson K. Differences in the extent of inflammation caused by intratracheal exposure to three ultrafine metals: Role of free radicals. J Toxicol Environ Health A 1998;53:423-438.

28. Dick CA, Brown DM, Donaldson K, Stone V. The role of free radicals in the toxic and inflammatory effects of four different ultrafine particle types. Inhal Toxicol 2003;15:39-52.

29. Warheit DB, Brock WJ, Lee KP, Webb TR, Reed KL. Comparative pulmonary toxicity inhalation and instillation studies with different TiO2 particle formulations: Impact of surface treatments on particle toxicity. Toxicol Sci 2005;88:514-524.

30. Warheit DB, Webb TR, Reed KL. Pulmonary toxicity studies with TiO2 particles containing various commercial coatings. Toxicologist 2003;72:298A.

31. Li N, Alam J, Venkatesan MI, Eiguren-Fernandez A, Schmitz D, Di Stefano E, Slaughter N, Killeen E, Wang X, Huang A, Wang M, Miguel AH, Cho A, Sioutas C, Nel AE. Nrf2 is a key transcription factor that regulates antioxidant defense in macrophages and epithelial cells: Protecting against the proinflammatory and oxidizing effects of diesel exhaust chemicals. J Immunol 2004;173:3467-3481.

32. Nel A. Air pollution-related illness: Effects of particles. Science 2005;308:804-806.

33. Silbajoris R, Ghio AJ, Samet JM, Jaskot R, Dreher KL, Brighton LE. In vivo and in vitro correlation of pulmonary map kinase activation following metallic exposure. Inhal Toxicol 2000;12:453-468.

34. Nel A. Air pollution-related illness: Effects of particles. Science 2005;309:1326-1326.

35. Oberdorster G, Gelein RM, Ferin J, Weiss B. Association of particulate air pollution and acute mortality: Involvement of ultrafine particles? Inhal Toxicol 1995;7:111-124.

36. Yin H, Too HP, Chow GM. The effects of particle size and surface coating on the cytotoxicity of nickel ferrite. Biomaterials 2005;26:5818-5826.

37. Soto KF, Carrasco A, Powell TG, Garza KM, Murr LE. Comparative in vitro cytotoxicity assessment of some manufactured nanoparticulate materials characterized by transmission electron microscopy. J Nanoparticle Res 2005;7:145-169.

38. Brown DM, Wilson MR, MacNee W, Stone V, Donaldson K. Size-dependent proinflamma-tory effects of ultrafine polystyrene particles: A role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol Appl Pharmacol 2001;175:191-199.

39. Oberdorster G, Finkelstein JN, Johnston C, Gelein R, Cox C, Baggs R, Elder AC. Acute pulmonary effects of ultrafine particles in rats and mice. Res Rep Health Eff Inst 2000;96:5-74:dicussion pp. 75-86.

40. Driscoll KE, Deyo LC, Carter JM, Howard BW, Hassenbein DG, Bertram TA. Effects of particle exposure and particle-elicited inflammatory cells on mutation in rat alveolar epithelial cells. Carcinogenesis 1997;18:423-430.

41. Oberdorster G, Yu CP. Lung dosimetry—considerations for noninhalation studies. Exp Lung Res 1999;25:1-6.

42. Oberdorster G, Ferin J, Gelein R, Soderholm SC, Finkelstein J. Role of the alveolar macrophage in lung injury: Studies with ultrafine particles. Environ Health Perspect 1992;97:193-199.

43. Webb DR, Wilson SE, Carter DE. Comparative pulmonary toxicity of gallium arsenide, gallium(III) oxide, or arsenic(III) oxide intratracheally instilled into rats. Toxicol Appl Pharmacol 1986;82:405-416.

44. Zhang Q, Kusaka Y, Zhu X, Sato K, Mo Y, Kluz T, Donaldson K. Comparative toxicity of standard nickel and ultrafine nickel in lung after intratracheal instillation. J Occup Health 2003;45:23-30.

45. Heinrich U, Muhle H, Hoymann HG, Mermelstein R. Pulmonary function changes in rats after chronic and subchronic inhalation exposure to various particulate matter. Exp Pathol 1989;37:248-252.

46. Warheit D, Webb T, Sayes C, Colvin V, Reed K. Pulmonary instillation studies with nanoscale TiO2 rods and dots in rats: Toxicity is not dependent upon particle size and surface area. Toxicol Sci 2006;9:227-336.

47. Schins RP. Mechanisms of genotoxicity of particles and fibers. Inhal Toxicol 2002;14:57-78.

48. Monarca S, Crebelli R, Feretti D, Zanardini A, Fuselli S, Filini L, Resola S, Bonardelli PG, Nardi G. Mutagens and carcinogens in size-classified air particulates of a northern Italian town. Sci Total Environ 1997;205:137-144.

49. Yamamoto A, Honma R, Sumita M, Hanawa T. Cytotoxicity evaluation of ceramic particles of different sizes and shapes. J Biomed Mater Res A 2004;68:244-256.

50. Hoet PH, Gilissen L, Nemery B. Polyanions protect against the in vitro pulmonary toxic-ity of polycationic paint components associated with the ardystil syndrome. Toxicol Appl Pharmacol 2001;175:184-190.

51. Derfus AM, Chan WCW, Bhatia SN. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 2004;4:11-18.

52. Kirchner C, Liedl T, Kudera S, Pellegrino T, Munoz Javier A, Gaub HE, Stolzle S, Fertig N, Parak WJ. Cytotoxicity of colloidal cdse and CdSe/ZnS nanoparticles. Nano Lett 2005;5:331-338.

53. Lovric J, Bazzi HS, Cuie Y, Fortin GR, Winnik FM, Maysinger D. Differences in subcel-lular distribution and toxicity of green and red emitting CdTe quantum dots. J Mol Med 2005;83:377-385.

54. Shiohara A, Hoshino A, Hanaki K, Suzuki K, Yamamoto K. On the cytotoxicity caused by quantum dots. Microbiol Immunol 2004;48:669-675.

55. Green M, Howman E. Semiconductor quantum dots and free radical induced DNA nicking. Chem Commun (Camb) 2005; 121-123.

56. Rancan F, Rosan S, Boehm F, Cantrell A, Brellreich M, Schoenberger H, Hirsch A, Moussa F. Cytotoxicity and photocytotoxicity of a dendritic C(60) mono-adduct and a malonic acid C(60) tris-adduct on jurkat cells. J Photochem Photobiol B 2002;67:157-162.

57. Hoet PH, Gilissen LP, Leyva M, Nemery B. In vitro cytotoxicity of textile paint components linked to the "Ardystil syndrome". Toxicol Sci 1999;52:209-216.

58. Ryser HJ. A membrane effect of basic polymers dependent on molecular size. Nature 1967;215:934-936.

59. Dekie L, Toncheva V, Dubruel P, Schacht EH, Barrett L, Seymour LW. poly-L-glutamic acid Derivatives as vectors for gene therapy. J Control Release 2000;65:187-202.

60. Goodman CM, McCusker CD, Yilmaz T, Rotello VM. Toxicity of gold nanoparticles func-tionalized with cationic and anionic side chains. Bioconjug Chem 2004;15:897-900.

61. Zhao X, Striolo A, Cummings PT. C60 binds to and deforms nucleotides. Biophys J 2005; 89:3856-3862.

62. Chiron JP, Lamande J, Moussa F, Trivin F, Ceolin R. [Effect of "micronized" C60 fullerene on the microbial growth in vitro]. Ann Pharm Fr 2000;58:170-175.

63. Scrivens WA, Tour JM, Creek KE, Pirisi L. Synthesis of C-14-labeled C-60, its suspension in water, its uptake by human keratinocytes. Am J Chem Soc 1994;116:4517-4518.

64. Satoh M, Matsuo K, Takanashi Y, Takayanagi I. Effects of acute and short-term repeated application of fullerene C60 on agonist-induced responses in various tissues of guinea pig and rat. Gen Pharmacol 1995;26:1533-1538.

65. Jia G, Wang H, Yan L, Wang X, Pei R, Yan T, Zhao Y, Guo X. Cytotoxicity of carbon nanomaterials: Single-wall nanotube, multi-wall nanotube, fullerene. Environ Sci Technol 2005;39:1378-1383.

66. Zakharenko LP, Zakharov IK, Lunegov SN, Nikiforov AA. [Demonstration of the absence of genotoxicity of fullerene C60 using the somatic mosaic method]. Dokl Akad Nauk 1994;335:261-262.

67. Xiao L, Takada H, Maeda K, Haramoto M, Miwa N. Antioxidant effects of water-soluble fullerene derivatives against ultraviolet ray or peroxylipid through their action of scavenging the reactive oxygen species in human skin keratinocytes. Biomed Pharmacother 2005;59:351-358.

68. Gharbi N, Pressac M, Hadchouel M, Szwarc H, Wilson SR, Moussa F. [60]Fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity. Nano Lett 2005;5:2578-2585.

69. Andrievsky GV, Kosevich MV, Vovk OM, Shelkovsky VS, Vashchenko LA. On the production of an aqueous colloidal solution of fullerenes. J Chem Soc Chem Commun 1995;12: 1281-1282.

70. Yamakoshi Y, Umezawa N, Ryu A, Arakane K, Miyata N, Goda Y, Masumizu T, Nagano T. Active oxygen species generated from photoexcited fullerene (C60) as potential medicines: O2* Versus 1O2. J Am Chem Soc 2003;125:12803-12809.

71. Yokoyama A, Sato Y, Nodasaka Y, Yamamoto S, Kawasaki T, Shindoh M, Kohgo T, Akasaka T, Uo M, Watari F, Tohji K. Biological behavior of hat-stacked carbon nanofibers in the subcutaneous tissue in rats. Nano Lett 2005;5:157-161.

72. Sayes CM, Fortner JD, Guo W, Lyon D, Boyd AM, Ausman KD, Tao YJ, Sitharaman B, Wilson LJ, Hughes JB, West JL, Colvin VL. The differential cytotoxicity of water-soluble fullerenes. Nano Lett 2004;4:1881-1887.

73. Colvin VL. The potential environmental impact of engineered nanomaterials. Nat Biotechnol 2003;21:1166-1170.

74. Oberdorster E. Toxicity of nC60 fullerenes to two aquatic species: Daphnia and largemouth bass. Abstr Pap Am Chem S 2004;227:U1233-U1233.

75. Oberdorster E. Manufactured nanomaterials (fullerenes, C-60) induce oxidative stress in the brain of juvenile largemouth bass. Environ Health Persp 2004;112:1058-1062.

76. Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI, Tyurina YY, Gorelik O, Arepalli S, Schwegler-Berry D, Hubbs AF, Antonini J, Evans DE, Ku BK,

Ramsey D, Maynard A, Kagan VE, Castranova V, Baron P. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 2005;289:L698-L708.

77. Shvedova AA, Castranova V, Kisin ER, Schwegler-Berry D, Murray AR, Gandelsman VZ, Maynard A, Baron P. Exposure to carbon nanotube material: Assessment of nanotube cytotoxicity using human keratinocyte cells. J Toxicol Environ Health A 2003;66:1909-1926.

78. Monteiro-Riviere NA, Nemanich RJ, Inman AO, Wang YY, Riviere JE. Multi-walled carbon nanotube interactions with human epidermal keratinocytes. Toxicol Lett 2005;155:377-384.

79. Warheit DB, Laurence BR, Reed KL, Roach DH, Reynolds GAM, Webb TR. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol Sci 2004;77:117-125.

80. Lam C-W, James JT, McCluskey R, Hunter RL. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci 2004;77:126-134.

81. Tsuchiya T, Oguri I, Yamakoshi YN, Miyata N. Novel harmful effects of [60]fullerene on mouse embryos in vitro and in vivo. FEBS Lett 1996;393:139-145.

82. Ungurenasu C, Airinei A. Highly stable C(60)/poly(vinylpyrrolidone) charge-transfer complexes afford new predictions for biological applications of underivatized fullerenes. J Med Chem 2000;43:3186-3188.

83. Dugan LL, Turetsky DM, Du C, Lobner D, Wheeler M, Almli CR, Shen CKF, Luh T-Y, Choi DW, Lin T-S. Carboxyfullerenes as neuroprotective agents. Proc Natl Acad Sci USA 1997;94:9434-9439.

84. Sayes CM, Liang F, Hudson JL, Mendez J, Guo W, Beach JM, Moore VC, Doyle CD, West JL, Billups WE, Ausman KD, Colvin VL. Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. Toxicol Lett 2006;161:135-142.

85. Oberdorster G, Ferin J, Lehnert BE. Correlation between particle size, in vivo particle persistence, lung injury. Environ Health Perspect 1994;102(Suppl 5): 173-179.

86. Service RF. American Chemical Society Meeting. Nanomaterials show signs of toxicity. Science 2003;300:243.

87. Oberdorster G. Pulmonary effects of inhaled ultrafine particles. Int Arch Occup Environ Health 2001;74:1-8.

88. Yeates DB, Mauderly JL. Inhaled environmental/occupational irritants and allergens: Mechanisms of cardiovascular and systemic responses. Introduction. Environ Health Perspect 2001;109(Suppl 4): 479-481.

89. Oberdorster G, Sharp Z, Atudorei V, Elder A, Gelein R, Lunts A, Kreyling W, Cox C. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A 2002;65:1531-1543.

90. GoldDR, Litonjua A, Schwartz J, LovettE, Larson A, Nearing B, Allen G, Verrier M, Cherry R, Verrier R. Ambient pollution and heart rate variability. Circulation 2000;101:1267-1273.

91. Liao D, Creason J, Shy C, Williams R, Watts R, Zweidinger R. Daily variation of particulate air pollution and poor cardiac autonomic control in the elderly. Environ Health Perspect 1999;107:521-525.

92. Oberdorster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 2004;16:437-445.

93. Rao DB, Wong BA, McManus BE, McElveen AM, James AR, Dorman DC. Inhaled iron, unlike manganese, is not transported to the rat brain via the olfactory pathway. Toxicol Appl Pharmacol 2003;193:116-126.

94. Conhaim RL, Eaton A, Staub NC, Heath TD. Equivalent pore estimate for the alveolar-airway barrier in isolated dog lung. J Appl Physiol 1988;64:1134-1142.

95. Maynard AD, Baron PA, Foley M, Shvedova AA, Kisin ER, Castranova V. Exposure to carbon nanotube material: Aerosol release during the handling of unrefined single-walled carbon nanotube material. J Toxicol Environ Health A 2004;67:87-107.

96. Kim S, Lim YT, Soltesz EG, De Grand AM, Lee J, Nakayama A, Parker JA, Mihaljevic T, Laurence RG, Dor DM, Cohn LH, Bawendi MG, Frangioni JV. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 2004;22:93-97.

97. Nel AE, Diaz-Sanchez D, Ng D, Hiura T, Saxon A. Enhancement of allergic inflammation by the interaction between diesel exhaust particles and the immune system. J Allergy Clin Immunol 1998;102:539-554.

98. Lademann J, Weigmann H, Rickmeyer C, Barthelmes H, Schaefer H, Mueller G, Sterry W. Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol Appl Skin Physiol 1999;12:247-256.

99. Tinkle SS, Antonini JM, Rich BA, Roberts JR, Salmen R, DePree K, Adkins EJ. Skin as a route of exposure and sensitization in chronic beryllium disease. Environ Health Perspect 2003;111:1202-1208.

100. Kreilgaard M. Influence of microemulsions on cutaneous drug delivery. Adv Drug Deliv Rev 2002;54(Suppl 1): S77-S98.

101. de Jalon EG, Blanco-Prieto MJ, Ygartua P, Santoyo S. Plga microparticles: Possible vehicles for topical drug delivery. Int J Pharm 2001;226:181-184.

102. Konaka R, Kasahara E, Dunlap WC, Yamamoto Y, Chien KC, Inoue M. Irradiation of titanium dioxide generates both singlet oxygen and superoxide anion. Free Radic Biol Med 1999;27:294-300.

103. Brezova V, Gabcova S, Dvoranova D, Stasko A. Reactive oxygen species produced upon photoexcitation of sunscreens containing titanium dioxide (An EPR study). J Photochem Photobiol B 2005;79:121-134.

104. Florence AT, Hussain N. Transcytosis of nanoparticle and dendrimer delivery systems: Evolving vistas. Adv Drug Deliv Rev 2001;50(Suppl 1): S69-S89.

105. Hussain N, Jaitley V, Florence AT. Recent advances in the understanding of uptake of mi-croparticulates across the gastrointestinal lymphatics. Adv Drug Deliv Rev 2001;50:107-142.

106. Florence AT, Hillery AM, Hussain N, Jani PU. Factors affecting the oral uptake and translocation of polystyrene nanoparticles: Histological and analytical evidence. J Drug Target 1995;3:65-70.

107. Hussain N, Jani PU, Florence AT. Enhanced oral uptake of tomato lectin-conjugated nanoparticles in the rat. Pharm Res 1997;14:613-618.

108. Hussain N, Florence AT. Utilizing bacterial mechanisms of epithelial cell entry: Invasin-induced oral uptake of latex nanoparticles. Pharm Res 1998;15:153-156.

109. Woodley JF. Lectins for gastrointestinal targeting—15 years on. J Drug Target 2000;7:325-333.

110. Hillyer JF, Albrecht RM. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci 2001;90:1927-1936.

111. Jani P, Halbert GW, Langridge J, Florence AT. Nanoparticle uptake by the rat gastrointestinal mucosa: Quantitation and particle size dependency. J Pharm Pharmacol 1990;42:821-826.

112. Jani P, Halbert GW, Langridge J, Florence AT. The uptake and translocation of latex nanospheres and microspheres after oral administration to rats. J Pharm Pharmacol 1989;41:809-812.

113. Chen BX, Wilson SR, Das M, Coughlin DJ, Erlanger BF. Antigenicity of fullerenes: Antibodies specific for fullerenes and their characteristics. Proc Natl Acad Sci USA 1998;95:10809-10813.

114. Kreyling WG, Semmler M, Erbe F, Mayer P, Takenaka S, Schulz H, Oberdorster G, Ziesenis A. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health A 2002;65:1513-1530.

115. Singh R, Pantarotto D, Lacerda L, Pastorin G, Klumpp C, Prato M, Bianco A, Kostarelos K. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc Natl Acad Sci USA 2006;103:3357-3362.

116. Wang B, Feng WY, Wang TC, Jia G, Wang M, Shi JW, Zhang F, Zhao YL, Chai ZF. Acute toxicity of nano- and micro-scale zinc powder in healthy adult mice. Toxicol Lett 2006;161:115-123.

117. Service RF. Nanotoxicology: Nanotechnology grows up. Science 2004;304:1732-1734.

118. Service RF. Is nanotechnology dangerous? Science 2000;290:1526-1527.

Was this article helpful?

0 0

Post a comment